Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept
Public ClinicalTrials.gov record NCT04947137. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT04947137
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Navidea Biopharmaceuticals
- Industry
- Enrollment
- 134 participants
Conditions and interventions
Conditions
Interventions
- Tc99m tilmanocept Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 26, 2021
- Primary completion
- Jan 20, 2022
- Completion
- Jan 20, 2022
- Last update posted
- Jan 7, 2025
2021 – 2022
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Marcus Research Clinic | Miami Lakes | Florida | 33014 | — |
| Innovation Medical Research Center | Palmetto Bay | Florida | 33157 | — |
| Kettering Medical Center | Kettering | Ohio | 45429 | — |
| Essential Medical Research | Tulsa | Oklahoma | 74137 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
| Tranquility Research | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04947137, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 7, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04947137 live on ClinicalTrials.gov.